| 2018-11-15 | Sale | G1 Therapeutics, Inc. GTHX | SVP & Chief Financial Officer | 10,000 0.0191% | $29.69 | $296,891 | -47.57% | |
| 2017-07-31 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 4,114 0.0012% | $0.89 | $3,661 | +36.06% | ||
| 2017-05-11 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 50,000 0.016% | $0.84 | $41,900 | +27.96% | ||
| 2017-01-31 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 3,266 0.001% | $1.12 | $3,658 | -11.45% | ||
| 2016-07-31 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 844 0.0002% | $4.29 | $3,621 | |||
| 2016-01-31 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 810 0.0003% | $4.38 | $3,548 | |||
| 2015-08-20 | Sale | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 20,000 0.0077% | $12.81 | $256,244 | -44.53% | |
| 2015-08-19 | Sale | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 37,312 0.0139% | $13.20 | $492,403 | -47.71% | |
| 2015-07-31 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 1,528 0.0001% | $2.28 | $3,484 | -42.95% | ||
| 2015-01-31 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 16,776 0.002% | $2.28 | $38,249 | |||
| 2014-10-03 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 5,000 0.0022% | $4.11 | $20,550 | +107.06% | ||
| 2014-07-31 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 17,576 0.0039% | $2.28 | $40,073 | +77.19% | ||
| 2014-03-25 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 5,000 0.0023% | $4.25 | $21,225 | +6.81% | ||
| 2014-01-31 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 19,736 0.004% | $2.29 | $45,195 | -12.5% | ||
| 2013-06-12 | Novavax, Inc. NVAX | SVP, Chief Financial Officer | 0 – | $0 | $0 | +104.97% |